Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid
- PMID: 14578026
Progression of osteosarcoma after high-dose methotrexate: over-rescue by folinic acid
Abstract
A 16-year-old girl with a distal femur osteosarcoma became pain-free with the first treatment of methotrexate 12.5 g/m(2) and folinic acid 760 mg/m(2). She was inadvertently given 1275 mg folinic acid after the third dose. Four days later, pain and swelling recurred. Appreciating that this was "over rescue" rather than drug resistance led to the successful use of a further 8 doses of high-dose methotrexate when a suboptimal response was achieved with cisplatinum, Adriamycin, and ifosfamide. This is the first time "over rescue" has been documented in humans from high-dose folinic acid after methotrexate.
Similar articles
-
Neoadjuvant chemotherapy with high-dose Ifosfamide, high-dose methotrexate, cisplatin, and doxorubicin for patients with localized osteosarcoma of the extremity: a joint study by the Italian and Scandinavian Sarcoma Groups.J Clin Oncol. 2005 Dec 1;23(34):8845-52. doi: 10.1200/JCO.2004.00.5785. Epub 2005 Oct 24. J Clin Oncol. 2005. PMID: 16246977 Clinical Trial.
-
Preoperative administration of high-dose methotrexate for osteosarcoma.Can J Surg. 1984 May;27(3):305-7, 309. Can J Surg. 1984. PMID: 6586272
-
[Adjuvant chemotherapy of osteosarcoma].Gan To Kagaku Ryoho. 1990 Feb;17(2):180-8. Gan To Kagaku Ryoho. 1990. PMID: 2301948 Japanese.
-
Osteosarcoma: review of the past, impact on the future. The American experience.Cancer Treat Res. 2009;152:239-62. doi: 10.1007/978-1-4419-0284-9_12. Cancer Treat Res. 2009. PMID: 20213394 Review.
-
An opinion supporting the role of high-dose methotrexate in the treatment of osteosarcoma.Cancer Treat Res. 1993;62:49-54. doi: 10.1007/978-1-4615-3518-8_9. Cancer Treat Res. 1993. PMID: 8096759 Review. No abstract available.
Cited by
-
Consensus Guideline for Use of Glucarpidase in Patients with High-Dose Methotrexate Induced Acute Kidney Injury and Delayed Methotrexate Clearance.Oncologist. 2018 Jan;23(1):52-61. doi: 10.1634/theoncologist.2017-0243. Epub 2017 Oct 27. Oncologist. 2018. PMID: 29079637 Free PMC article.
-
New recommendations for reversal of high-dose methotrexate cytotoxicity with folinic acid.Cancer Chemother Pharmacol. 2025 Mar 13;95(1):41. doi: 10.1007/s00280-025-04749-w. Cancer Chemother Pharmacol. 2025. Retraction in: Cancer Chemother Pharmacol. 2025 Jul 25;95(1):77. doi: 10.1007/s00280-025-04798-1. PMID: 40075030 Free PMC article. Retracted. Review.
-
Phase 2 study of glucarpidase in patients with delayed methotrexate elimination after high-dose methotrexate therapy.Cancer Chemother Pharmacol. 2024 Jul;94(1):89-101. doi: 10.1007/s00280-024-04664-6. Epub 2024 Mar 13. Cancer Chemother Pharmacol. 2024. PMID: 38478074 Free PMC article. Clinical Trial.
Publication types
MeSH terms
Substances
LinkOut - more resources
Medical